82X-42559-01744
2 vaccinations
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 980 / WA
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Registered in v-safe
-
2021-01-05
Dose 1 — Pfizer-BioNTech
- 2021-01-05
-
2021-01-06
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Muscle or body achesAdult check-in
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-14
- 2021-01-19
-
2021-01-26
Dose 2 — Pfizer-BioNTech
- 2021-02-02
- 2021-03-09
- 2021-07-27
-
2022-01-26
Survey response — 12 months, dose 2MedDRA: Nasopharyngitis, Pregnancy — Feeling: Good · Be unable to work or attend schoolFree text: Pregnancy, cold symptomsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Pfizer-BioNTech | |
| 2 | 2021-01-26 | Pfizer-BioNTech |
Free text
Release 11 — 12 months, dose 2
Symptoms: Pregnancy, cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release